Share on facebook Share on Twitter Share on Google Plus Share This

High Blood Pressure

High blood pressure (hypertension) is an increase in the force of blood against the arteries in the body. A blood pressure reading of 140/90 or higher indicates high blood pressure.

Programs + Services


Clinical Nutrition

The Division of Clinical Nutrition at Tufts Medical Center provides inpatient and outpatient nutritional services.
More information about programs and services


Preventive Cardiology Center

Explore the Preventive Cardiology Center at Tufts Medical Center in downtown Boston which specializes in cardiovascular disease prevention and treatment.
More information about programs and services


Women's Heart Center

Discover The Women’s Heart Clinic at Tufts Medical Center and learn more about the cardiologists dedicated to providing women with the best heart care.
More information about programs and services

Doctors + Care Team

Edward Saltzman, MD

Edward Saltzman, MD

Title(s): Chief, Division of Clinical Nutrition; Director, Adult Nutrition Support Services; Associate Professor, Tufts University School of Medicine; Dean for Education, Friedman School of Nutrition Science and Policy, Tufts University
Department(s): Medicine, Clinical Nutrition
Appt. Phone:
Fax #:

Enteral and parenteral nutrition

More Info

Andrew S. Greenberg, MD

Andrew S. Greenberg, MD

Title(s): Endocrinologist; Dr. Robert and Veronica Atkins Professor in Metabolism and Nutrition, Tufts University School of Medicine
Department(s): Medicine, Clinical Nutrition, Endocrinology, Diabetes and Metabolism
Appt. Phone: 617-556-3144
Fax #: 617-556-3224

Obesity, lipid disorders, diabetes, general endocrinology

More Info

Ayan R. Patel, MD

Ayan R. Patel, MD

Title(s): Director, Cardiovascular Imaging and Hemodynamic Laboratory; Director, Women's Heart Center; Professor, Tufts University School of Medicine
Department(s): Medicine, CardioVascular Center, Cardiology
Appt. Phone: 617-636-2273
Fax #: 617-636-8070

Echocardiography, heart failure, women's heart disease

More Info

Gordon S. Huggins, MD

Gordon S. Huggins, MD

Title(s): Director, Molecular Cardiology Research Institute (MCRI) Center for Translational Genomics; Cardiologist; Associate Professor, Tufts University School of Medicine
Department(s): Medicine, CardioVascular Center, Cardiology, Molecular Cardiology Research Institute
Appt. Phone: 617-636-2807
Fax #: 617-636-5649

Genetic mechanisms in cardiovascular cells including analysis of human trains and disease as a discovery platform biological studies, genetic susceptibility to heart and vascular diseases and molecular regulation of gene expression in cardiomyocytes and cardiomyocyte precursor cells.

More Info

Joel B. Mason, MD

Joel B. Mason, MD

Title(s): Gastroenterologist; Professor, Tufts University Schools of Medicine and Friedman School of Nutritional Science and Policy; Senior Scientist and Director, Vitamins and Carcinogenesis Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
Department(s): Medicine, Clinical Nutrition, Gastroenterology
Appt. Phone: 617-636-5883
Fax #: 617-636-1480

Nutritional aspects of gastrointestinal disease, home nutritional therapy, enteral and parenteral nutrition, nutrition and cancer prevention

More Info

Jonas B. Galper, MD, PhD

Jonas B. Galper, MD, PhD

Title(s): Director, Laboratory of Lipid Metabolism and CardioVascular Signaling, Molecular Cardiology Research Institute; Professor, Tufts University School of Medicine
Department(s): Medicine, CardioVascular Center, Cardiology
Appt. Phone: 617-636-2273
Fax #: 617-636-4833

General cardiology, molecular mechanisms of cardiovascular diseases

More Info

Research + Clinical Trials


A Prospective, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Macitentan in Patients with Pulmonary Hypertension after Left Ventricular Assist Device

This is a prospective, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to assess the efficacy and safety of macitentan in patients with pulmonary hypertension (PH) after left ventricular assist device implantation. The purpose of this study is to evaluate the effect of the study drug, macitentan, on the properties and function of the heart and on the blood pressure in the pulmonary arteries and to find out more about the safety of the study drug in subjects with PH after LVAD implantation. Macitentan is a study drug that works by blocking the effect of a substance called endothelin, which is produced in increased amounts in patients with pulmonary hypertension. Endothelin causes blood vessels to narrow (constrict), and overgrowth of the muscle in the walls of the blood vessels in the lung occurs. By blocking the action of endothelin, macitentan may reduce the blood pressure in the lung and improve activity level and wellbeing.In this study, half of the subjects will receive study drug/macitentan, while the other half of subjects will receive a placebo (inactive substance or sugar pill). he treatment period will last for about 12 weeks, with a follow-up period of 30 days. In total, including the screening period and a 30-day safety follow-up at the end of the study, the study will last no longer than 5.5 months, with up to 6 planned visits.
More information about research and clinical trials

Tufts Medical Center and Floating Hospital for Children have high quality care.

Quality + Safety

A world-class teaching hospital shouldn’t make you feel small.  At Tufts Medical Center the patient is at the center of everything that we do.  This means we’re committed to providing the highest quality of care in a safe, friendly environment.

Learn more
The City of Boston.

200 Years of Caring for the Community

Tufts Medical Center has been taking care of Boston and the surrounding community for more than 200 years.

Read about our enduring history